CTXR
Citius Pharmaceuticals Inc
NASDAQ: CTXR · HEALTHCARE · BIOTECHNOLOGY
$0.70
+16.96% today
Updated 2026-04-30
Market cap
$17.23M
P/E ratio
—
P/S ratio
4.37x
EPS (TTM)
$-2.46
Dividend yield
—
52W range
$1 – $2
Volume
0.7M
Citius Pharmaceuticals Inc (CTXR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-214.10%
ROE
-47.80%
ROA
-17.70%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | — | $-26341.00 | — | — | — |
| 2012 | — | $-22006.00 | — | — | — |
| 2013 | — | $-31369.00 | — | — | — |
| 2014 | $0.00 | $-1.27M | — | — | — |
| 2015 | $0.00 | $-2.90M | — | — | — |
| 2016 | $0.00 | $-8.30M | — | — | — |
| 2017 | $0.00 | $-10.38M | — | — | — |
| 2018 | $0.00 | $-12.54M | — | — | — |
| 2019 | $0.00 | $-15.58M | — | — | — |
| 2020 | $0.00 | $-17.55M | — | — | — |
| 2021 | $0.00 | $-23.13M | — | — | — |
| 2022 | $0.00 | $-33.64M | — | — | — |
| 2023 | $0.00 | $-32.54M | — | — | — |
| 2024 | $0.00 | $-39.14M | — | — | — |
| 2025 | $0.00 | $-37.43M | — | — | — |